Yubo International Biotech Ltd (YBGJ)
0.80
-0.10
(-11.10%)
USD |
OTCM |
May 17, 12:57
Yubo International Biotech Cash from Investing (TTM): 0.00 for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | -0.0398M |
March 31, 2023 | -0.0302M |
December 31, 2022 | -0.0398M |
September 30, 2022 | -0.0578M |
June 30, 2022 | 0.0222M |
Date | Value |
---|---|
March 31, 2022 | -0.1228M |
December 31, 2021 | -0.5647M |
September 30, 2021 | -0.5359M |
June 30, 2021 | -0.6412M |
March 31, 2021 | -0.5007M |
December 31, 2020 | -0.0975M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.6412M
Minimum
Jun 2021
0.0222M
Maximum
Jun 2022
-0.2006M
Average
-0.0578M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
Meihua International Medical Technologies Co Ltd | -12.46M |
Hologic Inc | -237.40M |
Nuwellis Inc | 0.399M |
Varex Imaging Corp | -58.60M |
Quanterix Corp | -257.46M |